HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jens Eickhoff Selected Research

lorukafusp alfa

12/2012Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.
11/2010Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.
9/2009Immunogenicity of the hu14.18-IL2 immunocytokine molecule in adults with melanoma and children with neuroblastoma.
3/2006A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
11/2004Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jens Eickhoff Research Topics

Disease

30Neoplasms (Cancer)
11/2022 - 11/2005
11Prostatic Neoplasms (Prostate Cancer)
01/2022 - 12/2005
5Hypotension (Low Blood Pressure)
01/2020 - 11/2004
4Neoplasm Metastasis (Metastasis)
01/2019 - 11/2005
4Fatigue
10/2014 - 09/2008
4Renal Cell Carcinoma (Grawitz Tumor)
03/2014 - 11/2005
4Melanoma (Melanoma, Malignant)
12/2012 - 11/2004
3Adenocarcinoma
01/2022 - 08/2008
3Infections
10/2020 - 01/2018
3Carcinogenesis
01/2020 - 03/2007
3Overweight
01/2018 - 04/2007
3Breast Neoplasms (Breast Cancer)
01/2016 - 07/2006
3Lymphocytosis
12/2012 - 11/2004
3Neuroblastoma
11/2010 - 03/2006
2Bites and Stings (Sting)
01/2022 - 10/2020
2End Stage Liver Disease
01/2022 - 10/2021
2Vomiting
01/2020 - 03/2014
2Nausea
01/2020 - 03/2014
2Insulin Resistance
01/2018 - 08/2007
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2015 - 08/2008
2Multiple Myeloma
10/2014 - 12/2008
2Neutropenia
05/2013 - 05/2008
2Hypoxia (Hypoxemia)
11/2010 - 11/2004
2Hyperbilirubinemia
11/2010 - 11/2004
2Thrombocytopenia (Thrombopenia)
05/2009 - 11/2004
1Ascites
01/2022
1Hepatitis
01/2022
1Liver Diseases (Liver Disease)
01/2022
1Liver Failure
01/2022
1Neonatal Abstinence Syndrome
11/2020
1Persistent Infection
10/2020
1Brucellosis (Malta Fever)
10/2020
1Lymphoma (Lymphomas)
01/2020
1Leukemia
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Radiation-Induced Neoplasms (Neoplasms, Radiation Induced)
01/2020
1Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2019
1Anemia
01/2019
1Neglected Diseases
11/2018

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
10/2020 - 03/2007
5lorukafusp alfaIBA
12/2012 - 11/2004
4Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2016
4Pharmaceutical PreparationsIBA
11/2020 - 06/2012
4Bortezomib (Velcade)FDA Link
10/2014 - 12/2008
3Docetaxel (Taxotere)FDA Link
01/2018 - 04/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016 - 12/2011
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2014 - 12/2008
3Sunitinib (Sutent)FDA Link
03/2014 - 12/2011
3Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2011 - 08/2008
33-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
01/2011 - 08/2008
3Monoclonal AntibodiesIBA
11/2010 - 11/2005
3Insulin (Novolin)FDA Link
08/2007 - 04/2007
2Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 05/2008
2Carboplatin (JM8)FDA LinkGeneric
11/2022 - 05/2008
2SodiumIBA
01/2022 - 10/2021
2Messenger RNA (mRNA)IBA
10/2020 - 06/2009
2Bevacizumab (Avastin)FDA Link
10/2017 - 03/2014
2Capecitabine (Xeloda)FDA Link
08/2015 - 02/2015
2VorinostatFDA Link
04/2014 - 12/2013
2Etoposide (VP 16)FDA LinkGeneric
04/2014 - 10/2005
2Valproic Acid (Depakote)FDA LinkGeneric
02/2013 - 01/2011
2Tyrosine Kinase InhibitorsIBA
04/2012 - 12/2011
2Transaminases (Aminotransferases)IBA
11/2010 - 11/2004
2Interleukin-2 (IL2)IBA
11/2010 - 03/2006
2Dopamine (Intropin)FDA LinkGeneric
11/2010 - 03/2006
2Growth Hormone (Somatotropin)IBA
03/2010 - 01/2008
2GemcitabineFDA Link
09/2008 - 08/2008
2Biological ProductsIBA
01/2008 - 07/2006
2NAD (NADH)IBA
12/2007 - 03/2007
2AntibodiesIBA
07/2006 - 11/2005
2Interleukin-2 Receptors (IL 2 Receptor)IBA
03/2006 - 11/2004
1talazoparibIBA
11/2022
1Prostate-Specific Antigen (Semenogelase)IBA
11/2021
1nasIBA
11/2020
1AntagomirsIBA
10/2020
1Type IV Secretion SystemsIBA
10/2020
1Toll-Like Receptor AgonistsIBA
10/2020
1InterferonsIBA
10/2020
1MicroRNAs (MicroRNA)IBA
10/2020
1LipopolysaccharidesIBA
10/2020
1pembrolizumabIBA
01/2020
13- (methylamino)- 2- ((methylamino)methyl)propane- 1- thiolIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Sulfhydryl Compounds (Thiols)IBA
01/2020
1Retinaldehyde (Retinal)IBA
01/2019
1IronIBA
01/2019
1Technetium Tc 99m MedronateIBA
01/2019
1Hemoglobins (Hemoglobin)IBA
01/2019
1Peptides (Polypeptides)IBA
11/2018
1Immunoglobulin G (IgG)IBA
11/2018
1ProteomeIBA
11/2018
1ElectrolytesIBA
01/2018

Therapy/Procedure

12Therapeutics
01/2022 - 10/2005
11Drug Therapy (Chemotherapy)
01/2020 - 05/2008
4Castration
01/2019 - 12/2016
3Liver Transplantation
01/2022 - 12/2013
2Drug Tapering
12/2012 - 09/2008
1Prostatectomy (Retropubic Prostatectomy)
01/2022
1Immunotherapy
01/2020